Literature DB >> 2346195

Risk factors for postvitrectomy fibrin formation.

G J Jaffe1, D Schwartz, D P Han, M Gottlieb, A Hartz, D McCarty, W F Mieler, G W Abrams.   

Abstract

We prospectively studied 194 patients undergoing vitrectomy between July 1988 and April 1989 to determine the incidence of postvitrectomy intraocular fibrin formation and the association of a variety of preoperative and intraoperative variables with the formation of severe postvitrectomy fibrin. Overall, 62 (32%) patients developed postvitrectomy fibrin; 25 (13%) had mild fibrin formation, 13 (6.5%) had moderate fibrin formation, and 24 (12.4%) had severe fibrin formation. By logistic multivariate analysis, preoperative factors that were independently predictive of severe fibrin formation included severe flare (P = .004), the presence of a previously placed scleral buckle (P = .001), and poor preoperative visual acuity (P = .007). Anterior epiretinal membrane dissection was the only intraoperative factor that was independently associated with an increased fibrin risk (P = .0003). A risk score derived from the multivariate analysis effectively categorized patients according to their likelihood of developing severe postvitrectomy fibrin. Results of this study may be useful in designing prophylactic interventions to decrease postvitrectomy fibrin formation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2346195     DOI: 10.1016/s0002-9394(14)72434-1

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  5 in total

1.  Vitrectomy with silicone oil infusion in severe diabetic retinopathy.

Authors:  A Castellarin; R Grigorian; N Bhagat; L Del Priore; M A Zarbin
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

2.  Preliminary study of the safety and efficacy of medium-chain triglycerides for use as an intraocular tamponading agent in minipigs.

Authors:  Vincent J Soler; Camille Laurent; Frédéric Sakr; Alain Regnier; Cyrielle Tricoire; Olivier Cases; Renata Kozyraki; Jean-Yves Douet; Véronique Pagot-Mathis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-05-25       Impact factor: 3.117

Review 3.  Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment.

Authors:  D G Charteris
Journal:  Br J Ophthalmol       Date:  1995-10       Impact factor: 4.638

4.  A prospective, open-label, dose-escalating study of low molecular weight heparin during repeat vitrectomy for PVR and severe diabetic retinopathy.

Authors:  R Gary Lane; J Michael Jumper; Ma'an A Nasir; Mathew W MacCumber; Brooks W McCuen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-03-03       Impact factor: 3.117

5.  Perfluorocarbon liquids as postoperative short-term vitreous substitutes in complicated retinal detachment.

Authors:  F Bottoni; M Sborgia; P Arpa; N De Casa; E Bertazzi; M Monticelli; V De Molfetta
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-11       Impact factor: 3.117

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.